Оптимизация методов спектрофлюориметрической диагностики поверхностного рака мочевого пузыря
Диссертация
Объективность оценки степени распространенности поверхностного РМП возросла с появлением методов, основанных на регистрации флюоресценции соединений, содержащихся в злокачественно трансформированных тканях организма, (и, в частности, порфиринов). Особенно перспективным направлением флюоресцентной диагностики является использование индукторов синтеза протопорфирина IX и, в частности… Читать ещё >
Содержание
- ГЛАВА 1. ОБЗОР ЛИТЕРАТУРЫ
- 1. 1. Клиническое значение совершенствования лечебно- 10 диагностической тактики при поверхностном РМП
- 1. 2. Современные принципы лечения поверхностного РМП
- 1. 3. Методы диагностики поверхностного РМП
- 1. 4. Флюоресцентные методы при поверхностном раке мочевого 16 пузыря
- 1. 4. 1. Естественная (эндогенная) флюоресценция в диагностике 16 поверхностного РМП
- 1. 4. 2. Значение флюоресцентной диагностики с 19 использованием экзогенных фотосенсибилизаторов
- 1. 4. 2. 1. Патогенетические механизмы 20 фотосенсибилизации и фотоповреждения
- 1. 4. 2. 2. Терапевтический вклад экзогенных 22 фотосенсибилизаторов
- 1. 4. 2. 3. Основные аспекты проведения флюоресцентной 25 диагностики при раке мочевого пузыря
- 1. 4. 2. 4. Флюоресцентная диагностика поверхностного 32 РМП с 5-аминолевулиновой кислотой
- 3. 1. Экспериментальная часть
Список литературы
- Алексеев Б.Я. Внутрипузырная иммунотерапия поверхностного рака мочевого пузыря // Автореф. дис. канд. мед. наук. — М., 1998. — 23 с.
- Аль-Шукри С.Х., Ткачук В. Н. Опухоли мочеполовых органов. СПб, 2000. -320 с.
- Анисимов П.М. Лучевые язвы мочевого пузыря // Вопросы эксперим. и клинич. Радиологии. 1966. — Вып. 2. — С. 191−194.
- Асламазов Э.Г., Долсуров Г. С., Саркисян Ю. Х., Агафонова Г. Б. Результаты комбинированного лечения больных раком мочевого пузыря // Урол. и нефрол. 1984. — № 4. — С. 27−31.
- Барский И.Я., Брумберг Е. М., Кондратьева Т. М. Ультрафиолетовая флюоресценция форменных элементов костного мозга и периферической крови животных и человека в норме и при патологии // Биофизика. 1960. -Том 6. — № 5. — С. 605−609.
- Блознелите Л., Пономарев И. Фотодинамическая терапия при опухолях различного гистогенеза // Врач. 1997. — № 3. — С. 24−26.
- Бутслов М.М. Каскадные электронно-оптические преобразователи и их применения // Пер. с анг. сб. статей. М.: Мир. 1965. — 448 с.
- Векшин Н.Л. Фотоника биологических структур // Пущино: ОНТИ, НЦБИ АН СССР. 1988. — 164 с.
- Верле Д., Гирт А., Богдан-Рай Т., Шнурпфайл Г. Фотодинамическая терапия рака: второе и третье поколение фотосенсибилизаторов // Известия Академии наук. Серия химическая. 1998. — № 5. — С. 836−845.
- Горелов С.И., Карелин М. И., Каган О. Ф., Старцев В. Ю. и соавт. // Материалы 1-ого Российского научного форума с международным участием «Лучевая диагностика и лучевая терапия на пороге третьего тысячелетия». Москва, 2000. — 159 с.
- Гуринович Г. П., Стрелкова Т. И. Спектроскопическое исследование ассоциации молекул в бинарных растворителях // Материалы XIII совещания «Физические проблемы спектроскопии». — Москва. 1962. — Т. 1.-С. 305−306.
- Зырянов Б.Н., Прокопьев В. Е., Селиванов С. П. Проблемы и перспективы спектрометрического метода диагностики рака мочевого пузыря // Тезисы докладов 1-го Всероссийского съезда онкологов. Москва. 1996. — С. 250.
- Карякин А.В. Спектральные исследования люминесценции злокачественных опухолей // Изд. АН СССР, серия физ. 1962. — Т. 26. -№ 4. — С. 94−99.
- Карякин А.В., Анисимова И. Н. Флюоресценция легочной ткани в норме и при раке легкого // Биофизика. 1962. — Том 7. — Вып. 2. — С. 145—149.
- Карякин А.В., Гладкова М. А., МилаеваМ. Сравнительные исследования спектров поглощения и флюоресценции сыворотки крови больных раком легкого и здоровых людей // Биофизика. 1961. — Том 7. — № 2. — С. 240 242.
- Коновалова Н.П., Сомякова Т. И. Биологические аспекты рецидивирования злокачественных опухолей // Эксп. онкол. 1988. — № 2. — С. 9−14.
- Красновский А.А. Синглентный молекулярный кислород и первичные механизмы фотодинамического действия оптического излучения // Итоги науки и техники. — 1992. Т. 3. — С. 63−132.
- Лейси А. Световая микроскопия в биологии // Пер. с англ. М.: Мир. 1992. — 464 с.
- Лопаткин Н.А., Камалов А. А., Кудрявцев Ю. В., Токарев Ф. В. Флюоресцентная диагностика рака мочевого пузыря // Урология. — 2000. — № 4.-С. 3−6.
- Лощенов В.Б., Стратонников А. А., Волкова А. И., Прохоров A.M. Портативная спектроскопическая система для флюоресцентной диагностики опухолей и контроля за фотодинамической терапией // Российский химический журнал. 1998. — Т. XLII. — № 5. — С. 50−53.
- Матвеев Б.П., Карякин О. Б., Сафиуллов К. Н., Фигурин К. М., Леви Д. Т., Ватин О. Е. Профилактика рецидивов поверхностного рака мочевого пузыря иммунотерапией БЦЖ // Урол. и нефрол. 1993. — № 5. — С. 27−29.
- Матвеев Б.П., Шипилов В. И., Романов В. А., Минакова Л. Р., Гориловский Л. М. Внутрипузырная химиотерапия рака мочевого пузыря адриамицином // Урол. и нефр. 1984. — № 5. — С. 6−9.
- Матвеев Б.П., Фигурин К. М. Международная классификация TNM онкоурологических заболеваний // Урол. и нефрол. — 1999. № 1. — С. 3238.
- Миронов А.Ф. Разработка сенсибилизаторов второго поколения на основе природных хлорофиллов // Рос. химический журнал. 1998. — Т. XLII. — № 5.-С. 23−36.
- Прокопьев В.Е. Биофизические механизмы воздействия низкоинтенсивного лазерного излучения на биологические ткани и оптические методы диагностики их состояния // Автореф. дисс. докт. мед. наук. Томск, 2004.
- Прокофьева В.В. Исследование слабых астрономических объектов методами телевизионной электроники // УФН. 1979. — Т. 127. — Вып. 3. -С. 500−526.
- Селиванов С.П. Диагностика и лечение поверхностного рака мочевого пузыря // Автореф. дисс. докт. мед. наук Томск, 2001. — 38 с.
- Селиванов С.П., Прокопьев В. Е., Удут В. В., Исаева С. Н. Трансуретральная резекция поверхностного рака мочевого пузыря под контролем флюоресценции // Клиническая Онкология и Гематология. -2001. Т. 1. — № 1.-С. 3−6.
- Черняева Е.Б., Степанова Н. В., Литинская Л. Л. // Итоги науки и техники. Сер. соврем, пробл. лазер, физ. ВИНИТИ. 1990. — Т. 3 — С. 136−224.
- Чиссов В.И., Соколов В. В., Булгакова Н. Н., Филоненко Е. В. Флюоресцентная эндоскопия, дермаскопия и спектрофотометрия в диагностике злокачественных опухолей основных локализаций // Рос. биотерапевтический журнал. 2003. — Том. 2. — № 4. — С. 45−56.
- Чиссов В.И., Соколов В. В., Филоненко Е. В. Фотодинамическая терапия злокачественных опухолей. Краткий очерк развития и опыт клинического применения в России // Рос. химический журнал. 1998. — Т. XLII. — № 5. -С. 5−9.
- Штепп Г., Вагнер С., Цаак Д., Кнюхель-Кларке Р. Флюоресцентная диагностика рака мочевого пузыря с использованием 5-аминолевулиновой кислоты основополагающие исследования и их результаты // Изд-во: Endo-Press. Туттлинген. Германия, 2000. — 58 с.
- Эмануэль Н.М. Кинетика экспериментальных опухолевых процессов. — М., 1977.-С. 414.
- Якубовская Р.И., Казачкина Н. И., Кармакова Л. А., и др. Скрининг и медико-биологическое изучение отечественных фотосенсибилизаторов // Российский химический журнал. 1998. — Т. XLII. — № 5. — С. 17−23.
- Якубовская Р.И., Соколов В. В., Немцова Е. Р. и др. Влияние фотодинамической терапии на состояние иммунной системы и антиоксидантный статус у онкологических больных // Рос. онкол. журнал.- 1997.-Т. 2.-С. 27−32.
- Agarwal M.L., Clay М.Е., Harvey E.J., Evans H.H., Antunez A.R., Oleinick N.L. Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells // Cancer Res. 1991. — Vol. 51. -P. 5993−5996.
- Agarwal M.L., Larkin H.E., Zaidi S.I., Mukhtar H., Oleinick N.L. Phospholipase activation triggers apoptosis in photosensitized mouse lymphoma // Cancer Res.- 1993. Vol. 53. — P. 5897−5902.
- Alfano R.R., Tata D.B., Tomashefsky P., Longo F.W., Alfano M.A. Laser induced fluorescence spectroscopy from native cancerous and normal tissue // I. E. E. E. Quantum Electron. 1984. — Vol. 20. -P. 1507−1511.
- Allison B.A., Pritchard P.H., Levy J.G. Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative // Br. J. Cancer. 1994. -Vol. 69.-P. 833−839.
- Allison B.A., Pritchard P.H., Richter A.M., Levy J.G. The plasma distribution of benzoporphyrin derivative and the effects of plasma lipoproteins on its biodistribution // Photochem. Photobiol. 1990. — Vol. 52. — P. 501−507.
- Andrejevic-Blant S., Hadjur C., Ballini J.P., et al. Photodynamic therapy of early sguamous cell carcinoma with tetra (m-hydroxyphenyl) chlorin: optimal drug-light interval // Br. J. Cancer. 1997. — Vol. 76. — P. 1021−1028.
- Andreoni A., Culbeddu R., De Silvestri S., Laporta P. Hematoporphyrin derivative: Photophysical properties and laser activation // Med. Biol. Environ. -1983.-Vol. 10.-N. l.-P. 261−268.
- Anidjar M., Cussenot O., Avrillier S., et al. The role of laser-induced autofluorescence spectroscopy in bladder tumor detection. Dependence on the excitation wavelength // Ann. N. Y. Acad. Sci. 1998. — Vol. 838. — P. 130−142.
- Anidjar M., Ettori D., Cussenot O., et al. Laser induced autofluorescence diagnosis of bladder tumors: dependence on the excitation wavelength // J. Urol. 1996. — Vol. 156. — N. 5. — P. 1590−1596.
- Bachor R., Hautmann R., Hasan T. Comparison of two routes of photosensitizer administration for photodynamic therapy of bladder cancer // Urol. Res. 1994. -Vol. 22.-N. l.-P. 21−23.
- Bachor R., Reich E., Ruck A., Hautmann R. Aminolevulinic acid for photodynamic therapy of bladder carcinoma cells // Urol. Res. 1996. — Vol. 24. -N. 5.-P. 285−289.
- Baert L., Berg R., Van Damme В., D’Hallewin M.A., Johansson J., Svanberg K., et al. Clinical fluorescence diagnosis of human bladder carcinoma following low-dose Photofrin injection // Urology. 1993. — Vol. 41. — P. 322−330.
- Barentsz J., Engelbrecht M., Jager G., Witjes J., et al. Fast dynamic gadolinium-enhanced MR imaging of urinary bladder and prostate cancer // J. Magn. Reson. Imaging. 1999. — Vol. 10. — P. 295−304.
- Barentsz J.O., Jager G.J., Witjes J.A., Ruijs J.H. Primary staging of urinary bladder carcinoma: the role of MRI and a comparison with CT // Eur. Radiol. -1996.-Vol. 6.-N. 2.-P. 129−133.
- Benson R.C., Farrow C.M., et al. Detection and localization of in situ carcinoma of the bladder with hematoporphyrin derivative // Mayo. Clin. Proc. 1982. -Vol. 57.-P. 548−555.
- Berenbaum M., Bonnett R., Cheorettan E. Selectivity of meso-tetra-(hydroxyphenyl) porphyrins and chlorins and photofrin in causing photodamage in tumor, skin, muscle and bladder // Laser. Med. Sci. 1993. — Vol. 8. — P. 235−243.
- Berg K., Moan J. Lysosomes and microtubules as targets for photochemotherapy of cancer // J. Photochem. Photobiol. 1997. — Vol. 65. — N. 3. — P. 403−409.
- Biel M. Photodynamic therapy and the treating of head and neck cancers // J. Clin. Laser. Radiat. Surg. 1996. — Vol. 14. — P. 239−244.
- Bochner B.H., Cote R.J., Weidner N., Groshen S., Chen S.C., Skinner D.G., Nichols P.W. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis // Natl. Cancer Inst. 1995. -Vol. 87. — N. 21. — P. 1603−1612.
- Bohmer R.M., Morstyn G. Uptake of hematoporphyrin derivative by normal and malignant cells: effect of serum, pH, temperature, and cell size // Cancer Res. -1985.-Vol. 45. -N. 11.-P. 5328−5334.
- Bonnett R., White R.D., Winfield U .J., Berenbaum M.C. Hydroporphyrins of the meso-tetra (hydroxyphenyl)porphyrin series as tumour photosensitizers // Biochem. J. 1989. — Vol. 261. — N. 1. — P. 277−280.
- Bown S.G., Millson C.E. Photodynamic therapy in gastroenterology // Gut. -1997.-Vol. 41.-P. 5−7.
- Brunner H., Hausmann F., Knuechel R. New 5-aminolevulinic acid esters-efficient protoporphyrin precursors for photodetection and photodynamic therapy // Photochem Photobiol. 2003. — Vol. 78. -N. 5. — P. 481−486.
- Bugelski P.J., Porter C.W., Dougherty T.J. Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse // Cancer Res. 1981 — Vol. 41.-N. 11.-P. 4606−4612.
- Burk K., Troller R., Pittner P. Prevention of recurrence in non-invasive bladder carcinoma. Experiences with 400 patients // Urologe Ausg. A. 1983. — Vol. 22. -P. 332−336.
- Bush I.M., Whitmore W.F. Occult cancer of the bladder. Its detection by ultraviolet tetracycline cystoscopy // J. Med. Soc. N. J. 1967. — Vol. — 64. — P. 56−60.
- Canete M., Villanueva A., Dominguez V., et al. Meso-tetraphennylporphyrin: photosensitizing properties and cytotoxic effects on cultured tumor cells // Int. J. Oncol. 1998. — Vol. 13. — P. 497−504.
- Carruth J.A. Clinical applications of photodynamic therapy // Int. J. Clin. Pract. 1998.-Vol. 52.-N. l.-P. 39−42.
- Catanzaro F., Torelli F., Catanzaro M., Cappellano F., Pizzoccaro M., Baruffi M., Sironi D., Pozzoli G.L. Conservative treatment of high-risk (T1G3) transitional carcinoma // Arch. Ital. Urol. Androl. 1996. — Vol. 68. — N. 1. — P. 21−24.
- Chang S.C., MacRobert A.J., Bown S.G. Photodynamic therapy on rat urinary bladder with intravesical instillation of 5-aminilevulinic acid: light diffusion and histological changes // J. Urol. 1996. — Vol. 155. — P. 1749−1753.
- Chen H., Hetzel F.W. Tumor oxygenation changes post-photodynamic therapy // Photochem. Photobiol. 1996. — Vol. 63. — P. 128−131.
- Christensen Т., Sandquist Т., Feren K., et al. Retention and photodynamic effects of haematoporphyrin derivative in cells after prolonged cultivation in the presence of porphyrin//Br. J. Cancer. 1983. — Vol. 48. -N. 1. — P. 35−43.
- Chung Y.G., Schwartz J.A., Gardner C.M., Sawaya R.E., and Jacques S.L. Diagnostic potential of laser-induced autofluorescence emission in brain tissue // J. Korean Med. Sci. 1997. -Vol. 12. -N. 2.-P. 135−142.
- Colasanti A., Kisslinger A., Fabbrocini G., Liuzzi R., Quarto M., Riccio P., Roberti G., and Villani F. MS-2 fibrosarcoma characterization by laser induced autofluorescence // Lasers Surg. Med. 2000. — Vol. 26. — N. 5. — P. 441−448.
- Cozzani I., Jori G., Reddi E., et al. Distribution of endogenous and injected porphyrins at the subcellular level in rat hepatocytes and in ascites hepatoma // Chem. Biol. Interact. 1981. — Vol. 37. -N. 1−2. -P. 67−75.
- Craft P. S., Harris A.L. Clinical prognostic significance of tumour angiogenesis // Ann. Oncol. 1994. — Vol. 5. — P. 305−311.
- Crawford E.D. Diagnosis and treatment of superficial bladder cancer: an update // Semin. Urol. Oncol. 1996. — Vol. 14. -N. 1. -P. 1−9.
- Cuenco G.M., Knisely T.L., Averboukh L., Garett L., Castro S., Cincotta A.H. Induction of glucose regulatory proteins in tumor cells after treatment with a benzophenothiazine analogue // Photochem. Photobiol. 1997. — Vol. 65. — 19 S.
- Daniltchenko D., Riedl C., Koenig F., Daha L.K., Sachs M., Schnorr D. The impact of ALA (5-aminolevulinic acid)-fluorescence detection on the prognosis of superficial bladder cancer // Aktuelle Urol. 2004. — Vol. 35. — N. 6. — P. 497−501.
- Datta S.N., Allman R., Loh C.S., et al. Photodynamic therapy of bladder cancer cell lines // Br. J. Urol. 1997. — Vol. 80. — P. 421 -426.
- Datta S.N., Loh C.S., MacRobert A.J., et al. Quantitative studies of the kinetics of 5-ALA induced Fluorescence in bladder transitional cell carcinoma // Br. J. Cancer.- 1998. Vol. 78.-N. 8.-P. 1113−1118.
- Dein A.B., Baz E.M., Aly A., Shamaa S., Ashamallah A. Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pTl): a randomized prospective study // J. Urol. 1997. — Vol. 158. -N. 1. — P. 68−73.
- De Jode M.L., Mcgilligan J.A., Dilkes M.G., Cameron I., Hart P.B., Grahn M.F. A comparison of novel light sources for photodynamic therapy // Lasers Med. Sci. 1997. — Vol. 12. — P. 260−268.
- D’Hallewin M.A., Baert L., Vanherzeele H. In vivo fluorescence detection of human bladder carcinoma without sensitizing agents // J. Am. Paraplegia. Soc. -1994.-Vol. 17.-N. 4.-P. 161−164.
- D’Hallewin M. A., Baert L., Vanherzeele H. Fluorescence imaging of bladder cancer // Acta Urol. Belg. 1994. — Vol. 62. — P. 49−52.
- D’Hallewin M.A., Bezdetnaya L., Guillemin F. Fluorescence detection of bladder cancer: a review // Eur. Urol. 2002. — Vol. 42. — N. 5. — P. 417−425.
- D’Hallewin M.A., De Witte P.A., Waelkens E., Merlevede W., Baert L. Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin// J. Urol. 2000. — Vol. 164.-N. 2.-P. 349−351.
- D’Hallewin M.A., Vanherzeele H., Baert L. Fluorescence detection of flat transitional cell carcinoma after intravesical instillation of aminolevulinic acid // Am. J. Clin. Oncol. 1998. — Vol. 21. -N. 3. — P. 223−225.
- Dickson J.A., Calderwood S.K. Effects of hyperglycemia and hyperthermia on the pH, glycolysis and respiration of the Yoshida sarcoma in vivo // J. Natl. Cancer Inst.-1979.-Vol. 63.-P. 1371−1381.
- Dickson E.F., Goyan R.L., Pottier R.H. New directions in photodynamic therapy // Cellular and Molecular Biology. 2003. — Vol. 48. — N. 8. — P. 939−954.
- Dolmans D.E., Fukumura D., Jain R.K. Photodynamic therapy for cancer // Nature Reviews Cancer. 2003. — Vol. 3. -N. 5. — P. 380−387.
- Dougherty T.J. A brief history of clinical photodynamic therapy development at Roswell Park Cancer Institute // J. Clin. Laser. Med. 1996. — Vol. 14. — P. 219−221.
- Dougherty T.J., Henderson B. Historical perspective: Schwartz S., Winkelman J.W., Lipson R.L. In: Henderson B.W., Dougherty T.J., editors. Photodynamic therapy. New York: Marcel Dekker Inc., 1992. — P. 1−15.
- Dougherty T.J., Kaufman J.E., Goldfarb A., et al. Photoradiation therapy for the treatment of malignant tumors // Cancer Res. — 1978. Vol. 38. — N. 8. — P. 2628−2635.
- Dugan M., Crawford E., Nseyo U. Photodynamic therapy (PDT) after transurethal resection (tur) for superficial papillary bladder carcinoma (SBC): a randomized trial // Proc. ASCO. 1991. — Vol. 10. — P. 173.
- Duque J.L., Loughlin K.R. An overview of the treatment of superficial bladder cancer. Intravesical chemotherapy // Urol. Clin. North. Am. 2000. — Vol. 27. -N. l.-P. 125−135.
- Edell E.S., Cortese D.A. Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection // Chest. 1992.-Vol. 102.-P. 1319−1322.
- Eden M., Haines В., Kahler H. The pH of rat tumors measured in vivo // J. Natl. Cancer. Inst. 1955. — Vol. 16. — P. 541−556.
- Egger N.G., Motamedi M., Pow-Sang M., et al. Accomulation of porohyrins in plasma and tissues of dogs after delta-aminolevulinic acid administration: implications for photodynamic therapy // Pharmacology. 1996. — Vol. 52. — P. 362−370.
- Evans S., Matthews W., Perry R., Fraker D., Norton J., Pass H.I. Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages // J. Natl. Cancer Inst. 1990. — Vol. 82. — P. 34−39.
- Evensen J.F., Moan J., Hindar A., Sommer S. Tissue distribution of 3H-hematoporphyrin derivative and its main components, 67Ga and 1311-albumin in mice bearing Lewis lung carcinoma // Prog. Clin. Biol. Res. 1984. — Vol. 170. -P. 541−562.
- Fan K.F., Hopper C., Speight P.M., Buonaccorsi G., MacRobert A.J., Bown S.G. Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity // Cancer. 1996. — Vol. 78. —P. 1374−1383.
- Filbeck Т., Wimmershoff M.B., Pichlmeier U., et al. No generalized skin phototoxicity after intravesical application of 5-aminolevulinic acid for fluorescence diagnosis of superficial bladder cancer // Urol. Int. 2000. — Vol. 64.-N. 3.-P. 126−128.
- Fingar V.H. Vascular effects of photodynamic therapy // J. Clin. Laser Med. Surg. 1996. — Vol. 14. — P. 323−328.
- Fingar V.H., Siegel К.A., Wieman T.J., Doak K.W. The effects of thromboxane inhibitors on the microvascular and tumor response to photodynamic therapy // Photochem. Photobiol. 1993. — Vol. 58. — P. 393−399.
- Fingar V.H., Wieman T.J., Haydon P. S. The effects of thrombocytopenia on vessel stasis and macromolecular leakage after photodynamic therapy using photofrin // Photochem. Photobiol. 1997. — Vol. 66. — P. 513−517.
- Fioretti P., Facchini V., Caducci A., Cozzani I. Monitoring of hematoporphyrin ingected in humans and clinical prospects of its use in gynecologic oncology // Porphyrins Tumor Photother.: Proc. Int. Symp. New York. London, 1984. — P. 355−361.
- Foote C.S. Mechanisms of photooxygenation // Prog. Clin. Biol. Res. — 1984. -P. 3−18.
- Freitas I. Lipid accumulation: the common feature to photosensitizer-retaining normal and malignant tissues // J. Photocem. Photobiol. B. 1990. — Vol. 7. — N. 2−4.-P. 359−361.
- Friedberg J., Mick R., Stevenson J., Zhu Т., Busch Т., et al. Phase II Trial of
- Pleural Photodynamic Therapy and Surgery for Patients With Non-Small-Cell1.ng Cancer With Pleural Spread // J. of Clin. Oncol. 2004. — Vol. 22. — N. 11. -P. 2192−2201.
- Furukawa K., Yamamoto H., Crean D.H. et al. Localization and treatment of transformed tissues using the photodynamic sensitizer 2-l-hexyloxyethyl.-2-devinyl pyropheophorbidera // Lasers. Surg. Med. — 1996. Vol. 18. — P. 157 166.
- Garbo G.M. Purpurins and benzochlorins as sensitizers for photodynamic therapy // J. Photochem. Photobiol. 1996. — Vol. 34. — N. 2−3. — P. 109−116.
- Gaullier J.M., Berg K., Peng Q., et al. Use of 5-aminolevulinic acid esters to impove photodynamictherapy on cells in culture // Cancer Res. 1997. — Vol. 57.-P. 1481−1486.
- Gerweck LE, Seetharaman K. Cellular pH gradient in tumor versus nor-mal tissue: potential exploitation for the treatment of cancer // Cancer Res. 1996. -Vol. 56.-P. 1194−1198.
- Gilissen M.J., van de Merbelde Wit L.E., Star W.M., Koster J.F., Sluiter W. Effect of photodynamic therapy on the endothelium-dependent relaxation of isolated rat aortas // Cancer Res. 1993. — Vol. 53. — P. 2548−2552.
- Gimbrone M.A., Cotran R.S., Leapman S.B., Folkman J. Tumor growth neovascularization: an experimental model using rabbit cornea // J. Nail. Cancer Inst.-1974.-Vol. 52.-P. 413−417.
- Gimbrone M.A., Leapman S.B., Cotran R.S., Folkman J. Tumor dormancy in vivo by prevention of neovascularization // J. Exp. Med. 1972. — Vol. 136. — P. 261−276.
- Gollnick S.O., Liu X., Owczarczak В., Musser D.A., Henderson B.W. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo // Cancer Res. 1997. — Vol. 57. — P. 3904−3409.
- Gomer G., Ferrario A. Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model // Cancer Res. — 1990. — Vol. 50. N. 13. — P. 3985−3990.
- Gomer C.J., Luna M., Ferrario A., Wong S., Fisher A., Rucker N. Cellular targets and molecular responses associated with photodynamic therapy // J. Clin. Laser. Med. Surg. 1996. — Vol. 14. — P. 315−321.
- Gottschlich S., Lippert B.M., Schade W., Werner J.A. Time-resolved fluorescence spectroscopy of a hematoporphyrin derivative used forphotodynamic therapy of cancer // Res. Communs. Mol. Pathol. Pharmacol. 1997. Vol. 98. — N. 2. — P. 237−240.
- Griffiths S.J., Heelis P.F., Haylett A.K., Moore J.V. Photodynamic therapy of ovarian tumours and normal cells using 5,10,15,20-tetra-(3-carboxymethoxyphenyl)-chlorin // Cancer Lett. 1998. — Vol. 125. — N. 1−2. -P. 177−184.
- Grimbergen M.C., Jonges T.G., Lock T.M., et al. Photodynamic diagnosis of bladder cancer with intravesical 5-aminolevulinic acid induced fluorescence // Europ. Urology. -2001. Vol. 39. -N. 5. — P. 37.
- Gronlund-Pakkanen S., Makinen K., Talja M., et al. The importance of fluorescence distribution and kinetics of ALA-induced PpIX in the bladder in photodynamic therapy // J. Photochem. Photobiol. B. 1997. — Vol. 38. — N. 2−3.-P. 269−273.
- Grossweiner L.I. Porphyric Pesticides Chemistry, Toxicology and Pharmaceutical Applications // Eds. Duke. S.O., Rebeiz K.A. Washington, 1994.-P. 73−75.
- He X.Y., Sikes R.A., Thomsen S., Chung L.W., Jacques S.L. Photodynamic therapy with photofrin II induces programmed cell death in carcinoma cell lines // Photochem. Photobiol. 1994. — Vol. 59. — P. 468−473.
- Heney N.M., Ahmed S., Flanagan M.J., et al. Superficial bladder cancer: Progression and recurrence // J. Urol. 1983. — Vol. 130. — P. 1083−1086.
- Henderson B.W., Dougherty TJ. How does photodynamic therapy work? // Photochem. Photobiol. 1992. — Vol. 55. — P. 145−157.
- Henderson B.W., Fingar V.H. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor // Cancer Res. — 1987. -Vol. 47.-P. 3110−3114.
- Henderson B.W., Vaughan L., Bellnier D.A., van Leengoed H., Johnson P.G., Oseroff A.R. Photosensitization of murine tumor, vasculature and skin by 5-aminolevulinic acid-induced porphyrin // Photochem. Photobiol. 1995. — Vol. 62.-P. 780−789.
- Hrkal Z., Cajthamlova H., GrebenovaD., BartasovaJ., KlamovaH., Marinov J. Selective photodynamic destruction of leukamickych bunek // Cas. Lek. Cesk2000.-Vol. 15.-P. 148−154.
- Huang Z., Zheng W., Xie S., Chen R, Zeng H., McLean D.I., Lui H. Laser-induced autofluorescence microscopy of normal and tumor human colonic tissue // Int. J. Oncol. 2004. — Vol. 24. — N. 1. — P. 59−63.
- Jichlinski P., Guillou L., Karlsen S.J., Malmstrom P.U., et all. Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer—a multicenter study // J. Urol. -2003.-Vol. 170.-N. l.-P. 226−229.
- Jichlinski P., Leisinger H.J. Fluorescence cystoscopy in the management of bladder cancer: a help for the urologist! // Urol. Int. 2005. — Vol. 74. -N. 2. -P. 97−101.
- Jichlinski P., Marti A., Guillou L., et al. First report on hexyl-ester aminolevulinic acid (h-ALA) induced fluorescence cystoscopy in superficial bladder cancer // Europ. Urology. 2001. — Vol. 39. — N. 5. — P. 37.
- Jichlinski P., Wagnireres G., Forrer M., et al. Clinical assessment of fluorescence cytoscopy during transurethral bladder resection in superficial bladder cancer // Urol. Res. 1997. — Vol. 25. — N. 1. — P. 3−6.
- Jichlinski P., Wagnireres G., Forrer M., et al. The clinical value of fluorescence cystoscopy in the detection of superficial transitional epithelial cell carcinoma of the bladder // Ann. Urol. 1997. — Vol. 31. — P. 43−48.
- Jocham D., Staehler G., Chaussy C., Hammer C., Lohrs U. Laserbehandlung von Blasentumoren nach Photosensibilisierung mit Hamatoporphyrin-Derivat // Urol. A. 1981. — Vol. 20. — P. 340−343.
- Jordan A.M., Weingarten J., Murphy W.M. Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologic grading? // Cancer. 1987. — Vol. 60. — P. 2766−2774.
- Lamm D.L., Griffith J.G. Intravesical therapy: Does it affect the natural history of bladder cancer? // Semin. Urol. 1992. — Vol. 10. — P. 39−44.
- Kamat A.M., DeHaven J.I., Lamm D.L. A potential adjunct to intravesical chemotherapy for bladder cancer // Proc. Annu. Meet. Am. Soc. Clin. Oncol. -1999.-Vol. 18.-A. 1319.
- Kato H., Aizawa К., Ono J., et al. Clinical measurement of tumor fluorescence using a new diagnostic system with hematoporphyrin derivative, laser photoradiation, and a spectroscope // Laser in Surgery and Medicine. — 1984. — Vol. 4.-N. l.-P. 49−58.
- Kelly J.F., Snell M.E. Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder // J. Urol. 1976. — Vol. 115. -P. 150−151.
- Kennedy J.C., Pottier R.H. Endogenous protoporphyrin IX, a clinical useful photosensitizer for photodynamic therapy // J. Photochem. Photobiol. B. — 1992. -Vol. 14.-P. 275−292.
- Kennedy J.C., Pottier R.H., Pross D.C. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience // J. Photochem. Photobiol. B. 1990. — Vol. 6. — P. 143−148.
- Kessel D., Luo Y. Mitochondrial photodamage and PDT-induced apopto-sis // J. Photochem. Photobiol. B. 1998. — Vol. 42. — P. 89−95.
- Kessel D., Luo Y., et al. The role of subcellular localization in initiation of apoptosis by photodynamic therapy // J. Photochem. Photobiol. 1997. — Vol. 65.-N. 3.-P. 422−426.
- Kessel D., Luo Y., Woodburn K., Chang C.K., Henderson B.W. Mechanisms of phototoxicity catalyzed by two porphycenes // Proc. SPIE. 1995. — Vol. 2392. -P. 122−128.
- Kessel D., Woodburn K., Gomer С J., Jagerovic N., Smith K.M. Photosensitization with derivatives of chlorin p6 // J. Photochem. Photobiol. B. -1995.-Vol. 28.-P. 13−8.
- Kessel D., Woodburn K., Henderson B.W., Chang C.K. Sites of photodamage in vivo and in vitro by a cationic porphyrin // Photochem. Photobiol. 1995. — Vol. 62.-P. 875−881.
- Kluck R.M., Martin S.J., Hoffman B.M., Zhou J.S., Green D.R., Newmeyer D.D. Cytochrome с activation of CPP32-like proteolysis plays a critical role in a Xenopus cell-free apoptosis system // E. M. В. O. J. 1997. — Vol. 16. — P. 4639−4649.
- Koenig F., McGovern F.J., Althausen A.F., et al. Laser induced autofluorescence diagnosis of bladder cancer // J. Urol. 1996. — Vol. 156. — N. 5. — P. 15 971 601.
- Koenig F., McGovern F.J., Enquist H., et al. Autofluorescence guided biopsy for the early diagnosis of bladder carcinoma // J. Urol. 1998. — Vol. 159. — N. 6. -P. 1871−1875.
- Koenig F., McGovern F. J., Lame R., et al. Diagnosis of the bladder carcinoma using protoporphyrin IX fluorescence induced by 5-aminolevulinic acid // Br. J. Mol. Intern.-1999.-Vol. 83.-N. l.-P. 129−135.
- Kongshaug M. Distribution of tetrapyrrole photosensitizers among human plasma proteins // Int. J. Biochem. 1992. — Vol. 24. — P. 1239−1265.
- Korbelik M. Induction of tumor immunity by photodynamic therapy // J. Clin. Laser. Med. Surg. 1996. — Vol. 14. — P. 329−334.
- Korbelik M. Low density lipoprotein receptor pathway in the delivery of Photofrin: how much is it relevant for selective accumulation of the photosensitizer in tumors? // J. Photochem. Photobiol. B. 1992. — Vol. 12. — P. 107−119.
- Korbelik M. The role of nitric oxide in the response of solid tumors to photodynamic therapy // Photochem. Photobiol.- 1997. Vol. 65. — 55S-56S.
- Korbelik M., Krosol G., Chaplin D.J. Photofrin uptake by murine macrophages // Cancer Res. 1991. — Vol. 51. — P. 2251−2255.
- Korbelik M., Krosol G., Olive P.L., Chaplin D.J. Distribution of Photofrin between tumour cells and tumour associated macrophages // Br. J. Cancer. -1991.-Vol. 64.-P. 508−512.
- Korbelik M., Naraparaju V.R., Yamamoto N. Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer // Br. J. Cancer. — 1997. Vol. 75. — P. 202−207.
- Koss L.G. Mapping of the urinary bladder: its impact on the concepts of bladder cancer // Hum. Pathol. 1979. — Vol. 10. — P. 533−548.
- Krieg R.C., Fickweiler S., Wolfbeis O.S., Knuechel R. Cell-type specific protoporphyrin DC metabolism in human bladder cancer in vitro // Photochem. Photobiol. 2000. — Vol. 72. — N. 2. — P. 226−233
- Kriegmair M., Baumgartner R., Knuechel R., et al. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid // Urology. 1994. — Vol. 44. — N. 6. — P. 836−841.
- Kriegmair M., Baumgartner R., Lumper W., et al. Early clinical experience with 5-ALA for the photodinamic therapy of superficial bladder cancer // Br. J. Urol. 1996. — Vol. 77. — P. 667−671.
- Kriegmair M., Waidelich R., Baumgartner R., et al. Photodynamic therapy of superficial bladder cancer. An alternative to radical cystectomy? // Urol. 1994. -Vol. 33.-P. 276−280.
- Kriegmair M., Waidelich R, Lumper W., et al. Integral photodynamic treatment of refractory superficial bladder cancer // J. Urol. 1995. — Vol. 154. — P. 13 391 341.
- Kriegmair M., Zaak D., Hofstetter A., et al. Transurethral resection (TUR) of bladder cancer controlled by 5-aminolevulinic acid induced fluorescence endoscopy (AFE) versus white light endoscopy // J Urol. -2000. Vol. 163. — P. 149.
- Krosl G., Korbelik M., Dougherty G.J. Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy // Br. J. Cancer. 1995. — Vol. 71. — P. 549−555.
- Krosl G., Korbelik M., Krosl J., Dougherty G.J. Potentiation of photody-namic therapy-elicited antitumor response by localized treatment with granulocyte-macrophage colony-stimulating factor // Cancer Res. 1996. — Vol. 56. — P. 3281−3286.
- Kurth K.H. Intravesical chemotherapy for superficial bladder tumors category Ta/Tl: who should be treated and how? // Semin. Urol. Oncol. 1996. — Vol. 14.-N. 1 — P. 30−35.
- Kurth K.H., Bouffioux C., Sylvester R., van der Meijden A.P., Oosterlinck W., Brausi M. Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group // Eur. Urol. 2000. — Vol. 37. — P. 1−9.
- Lang K., BolsenK., Stahl W., RuzickaT., SiesH., LehmannP., and Fritsch C. The 5-aminolevulinic acid-induced porphyrin biosynthesis in benign and malignant cells of the skin // J. Photochem. Photobiol. 2001. — V. 65 N. l P. 2934.
- Leung J. Photosensitizers in photodynamic therapy // Semin. Oncol. 1994. -Vol. 21.-P. 4−10.
- Leunig A., Rick K., Stepp H., et al. Photodynamic diagnosis of neoplasms of the mouth cavity after local administration of 5-aminolevulinic acid // Laryngorhinootologie. Vol. 75. — P. 459−464.
- Leveckis J., Burn J.L., Brown N.J., Reed W.R. Kinetics of endogenous protoporphyrin IX induction by aminolevulinic acid: preliminary studies in the bladder//J. Urol.// 1994.-Vol. 152.-P. 550−553.
- Lin C.W., Bellnier D., Prout Jr. G., Andrus W.S., Prescott R. Cystoscopic fluorescence detector for photodetection of bladder carcinoma with hematoporphyrin derivative // J. Urol. 1984. — Vol. 131. — P. 587−590.
- Liu X., Kim C.N., Yang J., Jemmerson R., Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome с // Cell. — 1996. Vol. 86. — P. 147−157.
- Loidl W., Schmidbauer J., Susani M., Marberger M. Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance? // Eur. Urol. 2005. — Vol. 47. — N. 3.-P. 323−326.
- Maffezzini M., Simonato A., Zanon M., Raber M., Carmignani G. Up-front intravesical chemotherapy for low stage, low grade recurrent bladder cancer // J. Urol.- 1996.-Vol. 155.-N. 1.-P. 91−33.
- Malik Z., Lugaci H. Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins // Br. J. Cancer. 1987. — Vol. 56. — P. 589−595.
- Malkowicz S.B. Intravestical therapy for superficial bladder cancer // Semin. Urol. Oncol. 2000. — Vol. 18. — N. 4. — P. 280−288.
- Malmstrom P. Improved patient outcomes with BCG immunotherapy vs. chemotherapy Swedish and worldwide experience // Eur. Urol. — 2000. — Vol. 37.-N. l.-P. 16−20.
- Marchetti P., Hirsch Т., Zamzami N., Castedo M., Decaudin D., Susin SA, et al. Mitochondrial permeability transition triggers lymphocyte apoptosis // J. Immunol. 1996. — Vol. 157. — P. 4830−4836.
- Marcus S.L., Sobel R.S., Golub A.L., et al. Photodynamic therapy and photodiagnosis using endogenous photosesitization induced by 5-aminolevulinic acid: current and development status // J. Clin. Laser. Med. Surg. 1996. — Vol. 14.-P. 59−66.
- McMahon K.S., Wieman T.J., Moore P.H., Fingar V.H. Effects of photodynamic therapy using mono-L-aspartyl chlorin e 6 on vessel constriction, vessel leakage, and tumor response // Cancer Res. 1994. — Vol. 54. — P. 5374−5379.
- Melamed M.R., Voutsa N.G., Grabstald H. Natural history and clinical behavior of in situ carcinoma of the human urinary bladder // Cancer. 1964. Vol. 17. -P. 1533−1545.
- Melekos M.D., Moutzouris G.D. Intravesical therapy of superficial bladder cancer // Curr. Pharm. Des. Curr. Pharm. Des. 2000. — Vol. 6. — N. 3. — P. 345 359.
- Moan J. Porphyrin photosensitization and phototherapy // Photochem. Photobiol. 1986. — Vol. 43. — P. 681−690.
- Moan J., Berg K., Bommer J.C., Western A. Action spectra of phthalocyanines with respect to photosensitization of cells // Photochem. Photobiol. 1992. -Vol. 56.-N. 2.-P. 171−175.
- Moan J., Smedshammer L., Christensen T. Photodynamic effects on human cells exposed to light in the presence of hematoporphyrin. pH effects // Cancer Lett. — 1980.-Vol. 9.-P. 327−332.
- Morgan A.R., Garbo G.M., Keck R.W., Selman S.H. New photosensitizers for photodynamic therapy: combined effect of metallopurpurin derivatives and light on transplantable bladder tumors // Cancer Res. 1988. — Vol. 48. -N. 1. — P. 194−198.
- Mori Y., Shima H., Ihara H., Yabumoto H., Taguchi K., Koike H., Nojima M., Yamamoto H., Ikoma F. Clinical study of primary carcinoma in situ of the bladder//HinyokikaKiyo.- 1996. -Vol. 42.-N. 1.-P. 17−21.
- Mourant J.R., Bigio I.J., Boyer J., et al. Spectroscopic diagnosis of bladder cancer with elastic light scattering // Lasers. Surg. Med. 1995. — Vol. 17. — N. 4.-P. 350−357.
- Nagamoto N., Saito Y., Ohta S., Sato M., Kanma K., Sagawa M., et al. Relation of lymphnode metastasis to primary tumor size and microscopic appearance of roentgenographically occult lung cancer // Am. J. Surg. Pathol. 1989. — Vol. 13.-P. 1009−1013.
- Nelson J.S., Liaw L.H., Orenstein A., Roberts W.G., Berns M.W. Mechanism of tumor destruction following photodynamic therapy with hematopor-phyrin derivative, chlorin, and phthalocyanine // J. Natl. Cancer Inst. 1988. — Vol. 80. -P. 1599−1605.
- Nichols M.G., Foster Т.Н. Oxygen diffusion and reaction kinetics in the photodynamic therapy of multicell tumor speroids // Phys. Med. Biol. 1994. -Vol. 39.-P. 2161−2181.
- Nomi M., Gohji K., Okamoto M., Takenaka A., Ono Y., Fujii A. Results of transurethral resection plus adjuvant intravesical chemotherapy for superficial bladder cancer// Int. J. Urol. 1998. — Vol. 5. -N. 6. — P. 534−539.
- Novo M., Heuttmann G., Diddens H. Chemical instability of 5-aminolevulinic acid used in the fluorescence diagnosis of bladder tumours // J. Photochem. Photobiol. B. 1996. — Vol. 34. — N. 2−3. — P. 143−148.
- Nseyo U.O. Photodynamic therapy // Clin. North. Am. 1992. — Vol. 19. -N. 3. -P. 591−599.
- Nseyo U.O., DeHaven J., Dougherty T.J., et al. Photodynamic therapy in the treatment of patients with resistant superficial bladder cancer: a long-term experience //J. Clin. Laser Med. Serg. 1998. — Vol. 16. -N. 1. — P. 61−68.
- Nseyo U.O., Lamm D.L. Therapy of superficial bladder cancer // Semin. Oncol. 1996. — Vol. 23. — N. 5. — P. 598−604.
- Nseyo U., Lamm D., Riggs D., et al. Long term experience with photodynamic therapy (PDT) in the management of superficial vesical transitional cell carcinoma (SVTCC) // Proc. Annu. Meet. Am. Assoc. Cancer Res. 1997. -Vol. 38.-A. 2524.
- Ogura Y., Sato K., Kato Т., Saito K., Enomoto K. Immunohistochemical analysis of expression of angiogenic factors and tumor angiogenesis in superficial bladder cancer // Nippon. Hinyokika Gakkai. Zasshi. 1998. — Vol. 89.-N. 5.-P. 529−553.
- Okamura K., Ono Y., Kinukawa T. Randomized study of single early instillation of tetrahydropyranyl-doxorubicin for a single superficial bladder carcinoma // Cancer. 2002. — Vol. 94. — P. 2363−2368.
- Ozen H., Akdas A., Alkibay F. Prognostic factors in superficial bladder cancer // Int. Urol. Nephrol. 1986. — Vol. 18. -N. 4. — P. 417−420.
- Parker S.L., Tong Т., Bolden S., et al. Cancer Statistics, 1997 // C. A. Cancer J. Clin. 1997. — Vol. 47. — P. 5−27.
- Parkin D.M., Pisani P., Ferlay J. Global cancer statistics // C. A. Cancer J. Clin. -1999.-Vol. 49.-P. 33−64.
- Pass H.I. Photodynamic therapy in oncology: mechanisms and clinical use // J. Nat. Cancer Inst. 1993. — Vol. 85. — N. 6 — P. 443−456.
- Pass H., Donington J. Photodynamic therapy for the management of pleural malignancies//Sem. Surg. Oncol. 1995.-Vol. 11.-P. 360−367.
- Peng Q., Berg K., Moan J., Kongshaug M., Nesland J.M. 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research // Photochem. Photobiol. 1997. — Vol. 65. — P. 235−251.
- Peng Q., Moan J., Cheng L.S. The effect of glucose administration on the uptake of photofrin II in a human tumor xenograft // Cancer Lett. 1991. — Vol. 58. — P. 29−35.
- Peng Q., Warloe Т., Berg K., Moan J., Kongshaug M., Giercksky K.E., et al. 5-Aminolevulinic acid-based photodynamic therapy: clinical research and future challenges // Cancer. 1997. — Vol. 79. — P. 2282−308.
- Policard A. Etudes surles aspects offerts par des tumure experimentases examime a la lumure de Woods // C. R. Soc. Biol. 1924. — Vol. 91. — P. 14 231 424.
- Pottier R., Chow Y.F., LaPlante J.P., Truscott T.G., Kennedy J.C., Beiner L.A. Non-invasive techniques for obtaining fluorescence excitation and emission spectra in vivo // Photochem. Photobiol. 1986. — Vol. 44. — P. 679−687.
- Pottier R., Kennedy J.C. The possible role of ionic species in selective biodistribution of photochemotherapeutic agents toward neoplastic tissue // J. Photochem. Photobiol. B. 1990. — Vol. 8. — P. 1−16.
- Pow-Sang J.M., Seigne J.D. Contemporary Management of Superficial Bladder Cancer // J. M. С. C. 2000. — Vol. 7. — N. 4. — P. 335−339.
- Prokop^ev V.E., Selivanov S.P. Spectroscopic criterion of diagnostics of malignant neoplasms on urinary bladder mucous membrane // Abst. The 5th Inter. Conf. «Atomic and molecular pulsed laser» Tomsk. — 2001. — P. 88.
- Qin В., Selman S.H., Payne K.M., Keck R.W., Metzger D.W. Enhanced skin allograft survival after photodynamic therapy. Association with lymphocyte inactivation and macrophage stimulation // Transplantation. 1993. — Vol. 56. -P. 1481−1486.
- Renschler M., Yuen A., Panella T. Photodynamic therapy trials with Lutetium Texaphyrin // Photochem. Photobiol. 1997. — Vol. 65. — P. 475.
- Riedl C.R., Plas E., Pfluger H. Fluorescence detection of bladder tumors with 5-aminolevulinic acid // J. Endourol. 1999. — Vol. 13. — N. 10. — P. 755−779.
- Riesenberg R., Fuchs C., Kriegmair M. Photodynamic effects of 5-aminolevulinic acid- induced porphyrin on human bladder carcinoma cells in vitro // Eur. J. Cancer. 1996. — Vol. 32. — P. 328−334.
- Ripley P.M. The physics of diode lasers // Lasers Med. Sci. 1996. — Vol. 11.-P. 71−78.
- Roberts DJ, Cairnduff F., Driver I., Dixon В., Brown S.B. Tumour vascular shutdown following photodynamic therapy based on polyhaematoporphyrin or 5-aminolaevulinic acid // Int. J. Oncol. 1994. — Vol. 5. — P. 763−768.
- Rosenthal I. Phthalocyanines as photodynamic sensitizers // Photochem. Photobiol.- 1991. -Vol. 53.-N. 6.-P. 859−870.
- Scattoni V., Da Pozzo L.F., Colombo R., Nava L., et al. Dynamic gadolinium-enhanced magnetic resonance imaging in staging of superficial bladder cancer // J. Urol. 1996. — Vol. 155. -N. 5. — P. 1594−1599.
- Shipley W.U. Non-invasive Management of Invasive Bladder Cancer: Lectures // Jpn. J. Clin. Oncol. 2003. — Vol. 33. — N. 11. — P. 592−594.
- Spinelli P. Endoscopie au laser avec fluorescence et photohimiotherapie du cancer// Acta Endosc. 1983. -Vol. 13.-N. 3.-P. 201−205.
- Steinbach P., Kriegmair M., Baumgartner R., et al. Intravesical instillation of 5-aminolevulinic acid: The fluorescent metabolite is limited to urothelial cells // J. Urol. 1994. — Vol. 44. -N. 5. — P. 676−681.
- Stenzl A., Holtl L., Bartsch G. Fluorescence assisted transurethral resection of bladder tuvours: is it cost effective? // Europ. Urology. 2001. — Vol. 39. — N. 5. -P. 31.
- SteppH. 10th Congress of the European Society of Photobiology, Vienna, Avstria, 2003. Abstract Book. P. 56.
- Stepp H., Wagner S., Zaak D., Knuchel R. Fluorescence diagnosis of bladder tumor by use of 5-aminolevulinic acid — Fundamentals and results // Eds. R. Baumgartner. 1998. — P. 39−41.
- Stocker S., KnEuchel R., Sroka R., et al. Wavelength dependent photodynamic effects on chemically induced rat bladder tumors following intravesical instillation of 5-aminolevulinic acid // J. Urol. 1997. — Vol. 157. — P. 357−361.
- Sugimura Y., Hayashi N., Yamashita A., Kinbara H., et al. Endorectal magnetic resonance imaging of the prostate and bladder // Hinyokika Kiyo. 1994. — Vol. 40.-N. 1.-P. 31−36.
- Sutherland R.M., McCredie J.A., Inch W.R. Growth of multicell spheroids in tissue culture as a model of nodularcarcinomas // J. Nail. Cancer Inst. 1971. — Vol. 46.-P. 113−120.
- Tannock I.F., Rotin D. Acid pH in tumors and its potential for therapeutic exploitation // Cancer Res. 1989. — Vol. 49. — P. 4373−4384.
- Tatsuta M., Yamamoto R., Yamamura H., et al. Photodynamic effects of exposure to hematoporphyrin derivatives and dye laser radiation on human gastric adenocarcinoma cells // J. Nat. Canser Inst. 1984. — Vol. 73. — N. 1. -P. 59.
- Tekes A., Kamel I., Imam K., et al. Dynamic MRI of bladder cancer: evaluation of staging accuracy //A. J. R. 2005. — Vol. 184. — P. 121−127.
- Tekes A., Kamel I., Imam K., Chan Т., Schoenberg M. Bluemke D. MR imaging features of transitional cell carcinoma of the urinary bladder // A. J. R. 2003. -Vol. 180.-P. 771−777.
- Tochner A.Z., Pass H.I., Smith P.D., DeLaney T.F., Sprague M., DeLuca A.M., et al. Intrathoracic photodynamic therapy: a canine normal tissue tolerance study and early clinical experience // Lasers Surg. Med. 1994. — Vol. 14. — P. 118 123.
- Thomas J.P., Girotti A.W. Glucose administration augments in vivo uptake and phototoxicity of the tumor-localizing fraction of hematoporphyrin derivative // Photochem. Photobiol. 1989. — Vol. 49. — P. 241−247.
- Tian Мао-en., et. al. Photodynamic therapy bladder transitional cell cancer with hematoporphyrin derivative // Chin. J. Oncol. -1989. Vol. 11. -N. 4. — P. 304 306.
- Tomio L., Zorat P.L., Jori G., et al. Elimination pathway of hematoporphyrin from normal and tumor bearing rats // Tumori. — 1982. — Vol. 68. N. 1. — P. 283−286.
- Uehlinger P., Zellweger M., Wagnieres G., et al. 5-Aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells // J. Photochem. Photobiol. B. 2000. — Vol. 54. — N. 1. — P. 7280.
- Van Staveren H.J., Beek J.F., Keijzer M., Star W.M. Integrating sphere effect in whole-bladder-wall photodynamic therapy: II. The influence of urine at 458, 488, 514 and 630 nm optical irradiation // Phys. Med. Biol. 1995. — Vol. 40. -P. 1307−1311.
- Van Staveren H.J., Bertrams R.H., Star W.M. Bladder PDT with intravesical clear and light scattering media: effect of an eccentric isotropic light source on the light distribution // Lasers Surg. Med. 1997. — Vol. 20. — P. 248−253.
- Vaucher L., Lange N., Ritter-Schenk C., et al. Phototoxic effects in the protoporphyrin IX loaded urothelium // Europ. Urology. 2001. — Vol. 39. — N. 5.-P. 173.
- Vrouenraets M.B., Visser G.W., Snow G.B., van Dongen G.A. Basic principles, applications in oncology and improved selectivity of photodynamic therapy // Anticancer Research. 2003. — Vol. 23. — P. 505−522.
- Wagnieres G.A., Star W.M., Wilson B.C. In vivo fluorescence spectroscopy and imaging for oncological applications // Photochem. Photobiol. 1998. — Vol. 68. -P. 603−632.
- Waidelich R., Hofstetter A., Stepp H., et al. Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of upper tract urothelial tumors // J. Urol. 1998. — Vol. 159. — N. 2. — P. 401−404.
- Walther M.M., Delaney T.F., Smith P.D., et al. Phase I trial of photodynamic therapy in the treatment of recurrent superficial transitional cell carcinoma of the bladder // Urology. 1997. — Vol. 50. — P. 199−206.
- Walther M.M., Eanes E.D., Delaney T.F., Travis W.D. Bladder calcifications after photodynamic therapy: analysis of a rare complication // Urology. 1996. -Vol. 47.-P. 831−835.
- Webber J., Kessel D., Fromm D. Side effects and photosensitization of human tissues after aminolevulinic acid // J. Surg. Res. 1997. — Vol. 68. — P. 31−37.
- Webber J., Luo Y., Crilly R., Fromm D., Kessel D. An apoptotic response to photodynamic therapy with endogenous protoporphyrin in vivo // J. Photochem. Photobiol. B. 1996. — Vol. 35. — P. 209−211.
- Weidner N. Folkman J. Tumoral vascularity as a prognostic factor in cancer // Important. Adv. Oncol. 1996. — P. 167−190.
- Weishaupt K.R., Gomer С .J., Dougherty T.J. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor // Cancer Res. — 1976. Vol. 36. — N. 3. — P. 2326−2329.
- Whitmore W.F., Bush I. Ultraviolet cystoscopy // J. A. M. A. 1986. Vol. — P. 203.-P. 153−155.
- Whitmore W.F., Bush I.M., Esquivel E. Tetracycline ultraviolet fluorescence in bladder carcinoma // Cancer. 1964. — Vol. 17. — P. 1528−1532.
- Wile A.G., Dahlman A., Burns R.G., Berns M.W. Laser photoradiation therapy of cancer following hematoporphyrin sensitization // Lassers Sung. Med. 1982. -Vol. 2.-N. l.-P. 163−168.
- Williams R.D., Runge T.C. Photodynamic therapy of human bladder cancer cells in vitro correlated with cellular fluorescence levels of Photofrin-II // J. Photochem. Photobiol. 1987. -Vol. 46. — N. 5. — P. 733−737.
- Wyld L., Smith O., Lawry J., et al. Cell cycle phase influences tumour cell sensitivity to aminolaevulinic acid-induced photodynamic therapy in vitro // Br. J. Cancer. 1998. — Vol. 78. — N. 1. — P. 50−55.
- Xue L.Y., He J., Oleinick N.L. Rapid tyrosine phosphorylation of HS1 in the response of mouse lymphoma L5178Y-R cells to photodynamic treatment sensitized by the phthalocyanine Pc 4 // Photochem. Photobiol. 1997. — Vol. 66.-P. 105−113.
- Yamamoto N., Hoober J.K., Yamamoto N., Yamamoto S. Tumoricidal capacities of macrophages photodynamically activated with hematoporphyrin derivative // Photochem. Photobiol. 1992. — Vol. 56. — P. 245−250.
- Zaak D., Kriegmair M., Stepp H., Baumgartner R., Oberneder R., Schneede P., et al. Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopies // Urology 2001. — Vol. 57. — P. 690−694.
- Zaak D., Stepp H., Baumgartner R., Schneede P., et al. Ultraviolet-excited (308 nm) autofluorescence for bladder cancer detection // Urology. 2002. — Vol. 60. -P. 6.-P. 1029−1033.
- Zaak D., Wagner S., Stepp H., et al. Fluoreszenzquantifizierung bei der 5-Aminolavulinsaure induzierten Fluoreszenzendoskopie des oberflachlichen Harnblasenkarzinoms // Akt. Urol. 1998. — Vol. 29. — P. 39.
- Zaidi S.I., Oleinick N.L., Zaim M.T., Mukhtar H. Apoptosis during photodynamic therapy-induced ablation of RIF-1 tumors in C3H mice: electron microscopic, histopathologic and biochemical evidence // Photochem. Photobiol. 1993. — Vol. 58. — P. 771−776.
- Zumbraegel A., Feil G., Krause S., Bichler K.H. Photodynamic diagnosis (PDT) and analysis of DNA-ploidy for detection of dysplasias of the urinary bladder // Europ. Urology. 2001. — Vol. 39. -N. 5. — P. 37.
- Zimmern P.E., Laub D., Leach G.E. Fluorescein angiography of the bladder: technique and relevance to bladder cancer and interstitial cystitis // J. Urol. // 1995.-Vol. 154.-P. 62−65.
- Zungri E., Martinez L., Da Silva E.A., Pesqueira D., de la Fuente Buceta A., Pereiro В. T1 GUI bladder cancer. Management with transurethral resection only // Eur. Urol. 1999. — Vol. 36. -N. 5. — P. 380−384.